UBS Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)
Go back to UBS Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)| (NASDAQ: MDGL) | Delayed: 519.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $519.09 | 52 Week High | $18.24 | |||
| Open | $519.09 | 52 Week Low | $6.60 | |||
| Day High | $519.09 | P/E | N/A | |||
| Day Low | $519.09 | EPS | $0.00 | |||
| Volume | 243 | |||||

